MwanzoRGLS • NASDAQ
add
Regulus Therapeutics Inc
$ 1.47
Baada ya Saa za Kazi:(2.72%)+0.040
$ 1.51
Imefungwa: 22 Nov, 17:20:00 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 1.40
Bei za siku
$ 1.37 - $ 1.48
Bei za mwaka
$ 1.08 - $ 3.79
Thamani ya kampuni katika soko
96.29M USD
Wastani wa hisa zilizouzwa
elfu 407.53
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 14.19M | 81.62% |
Mapato halisi | -14.06M | -79.73% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.21 | 47.50% |
EBITDA | -15.12M | -87.38% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 87.31M | 183.64% |
Jumla ya mali | 93.76M | 148.40% |
Jumla ya dhima | 6.96M | -26.67% |
Jumla ya hisa | 86.80M | — |
hisa zilizosalia | 65.50M | — |
Uwiano wa bei na thamani | 1.05 | — |
Faida inayotokana na mali | -38.43% | — |
Faida inayotokana mtaji | -40.53% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -14.06M | -79.73% |
Pesa kutokana na shughuli | -9.45M | -50.53% |
Pesa kutokana na uwekezaji | 18.64M | 442.72% |
Pesa kutokana na ufadhili | elfu 56.00 | -80.49% |
Mabadiliko halisi ya pesa taslimu | 9.25M | 180.94% |
Mtiririko huru wa pesa | -4.32M | -55.64% |
Kuhusu
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Ilianzishwa
Sep 2007
Tovuti
Wafanyakazi
32
